Decreased level and defective function of circulating endothelial progenitor cells in children with Moyamoya disease

Journal of Neuroscience Research

Volumn 88, Issue 3, 2010, Pages 510-518

  Kim, Jin Hyun ^a   Jung, Ji Hye ^b   Phi, Ji Hoon ^b,c   Kang, Hyun Seung ^b   Kim, Jeong Eun ^b   Chae, Jong Hee ^c   Kim, Sang Jeong ^b   Kim, Young Hoon ^b   Kim, Young Yim ^b   Cho, Byung Kyu ^b,c   Wang, Kyu Chang ^b,c   Kim, Seung Ki ^b,c  

^a Gyeongsang National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Children's Hospital   (South Korea)

Author keywords

CD34+ cells; Clusters; Endothelial progenitor cells; KDR + cells; Moyamoya disease

Indexed keywords

CD133 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; ASSAY; CD34 SELECTION; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CEREBROVASCULAR DISEASE; CHILD; CIRCULATION; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; MOYAMOYA DISEASE; PATHOGENICITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENESCENCE; STEM CELL; VOLUNTEER;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD34; BRAIN INFARCTION; CAPILLARIES; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; ENDOTHELIAL CELLS; FEMALE; GLYCOPROTEINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MOYAMOYA DISEASE; PEPTIDES; STEM CELLS; TIME FACTORS; YOUNG ADULT;

EID: 73949145322     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22228     Document Type: Article

References (29)

1. 125I-PDGF binding and down-regulation of PDGF receptor in arterial smooth muscle cells derived from patients with moyamoya disease. J Cell Physiol 154:281-288.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
3. + cell mobilization. J Neurol 254:327-332.
4. Fadini GP, Agostini C, Avogaro A. 2005. Endothelial progenitor cells in cerebrovascular disease. Stroke 36:1112-1113.
5. + endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37:2277-2282.
6. Fukuhra S, Sakurai A, Yamagishi A, Sako K, Mochizuki N. 2006. Vascular endothelial cadherin-mediated cell-cell adhesion regulated by a small GTPase, Rap1. J Biochem Mol Biol 31:132-139.
7. Fukui M. 1997. Current state of study on moyamoya disease in Japan. Surg Neurol 47:138-143.
8. Ghani U, Shuaib A, Salam A, Nasir A, Shuaib U, Jeerakathil T, Sher F, O'Rourke F, Nasser AM, Schwindt B, Todd K. 2005. Endothelial progenitor cells during cerebrovascular disease. Stroke 36:151-153.
9. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109:625-637.
10. Hojo M, Hoshimaru M, Miyamoto S, Taki W, Nagata I, Asahi M, Matsuura N, Ishizaki R, Kikuchi H, Hashimoto N. 1998. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg 89:623-629.
11. Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M. 1991. Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg 75:267-270.
12. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. 2004. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293.
13. Jie KE, Goossens MH, van Oostrom O, Lilien MR, Verhaar MC. 2009. Circulating endothelial progenitor cell levels are higher during childhood than in adult life. Atherosclerosis 202:345-347.
14. Jung KH, Chu K, Lee ST, Park HK, Kim DH, Kim JH, Bahn JJ, Song EC, Kim M, Lee SK, Roh JK. 2008. Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease. J Cereb Blood Flow Metab. 28:1795-1803.
15. Kim SK, Wang KC, Kim IO, Lee DS, Cho BK. 2002. Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal) synangiosis in pediatric moyamoya disease. Neurosurgery 50:88-96.
16. Kim SK, Yoo JI, Cho BK, Hong SJ, Kim YK, Moon JA, Kim JH, Chung YN, Wang KC. 2003. Elevation of CRABP-I in the cerebro-spinal fluid of patients with moyamoya disease. Stroke 34:2835-2841.
17. Malek AM, Connors S, Robertson RL, Folkman J, Scott RM. 1997. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. Pediatr Neurosurg 27:182-189.
18. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. 2001. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 938:221-229.
19. Rafat N, Beck GCh, Peña-Tapia PG, Schmiedek P, Vajkoczy P. 2009. Increased levels of circulating endothelial progenitor cells in patients with moyamoya disease. Stroke. 40:432-438.
20. Shantsila E, Watson T, Tse HF, Lip GY. 2007. Endothelial colony forming units: are they a reliable marker of endothelial progenitor cell numbers? Ann Med 39:474-479.
21. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T. 2001. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779.
22. Suzuki J, Kodama N. 1983. Moyamoya disease: a review. Stroke 14:104-109.
23. Taguchi A, Matsuyama T, Moriwaki H, Hayashi T, Hayashida K, Nagatsuka K, Todo K, Mori K, Stern DM, Soma T, Naritomi H. 2004. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 109:2972-2975.
24. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. 1999. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434-438.
25. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:e1-e7.
26. Vestweber D. 2008. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol. 28:223-232.
27. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, Kojima M, Lin Y, Ohno Y. 1997. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 99(Suppl 2):S1-S5.
28. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G. 2003. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93:e17-e24.
29. Yoshihara T, Taguchi A, Matsuyama T. 2008. Increase in circulating CD34-positive cells in patients with angiographic evidence of moyamoya-like vessels. J Cereb Blood Flow Metab 1-4.